Download PDF
Z Gastroenterol 2022; 60(03): 299-309
DOI: 10.1055/a-1708-0277
Originalarbeit

Quality of life and sleep in individuals with irritable bowel syndrome according to different diagnostic criteria and inflammatory bowel diseases: A comparison using data from a population-based survey

Lebensqualität und Schlaf bei Personen mit Reizdarmsyndrom gemäß unterschiedlicher diagnostischer Kriterien sowie chronisch-entzündlichen Darmerkrankungen: Eine Auswertung populationsbasierter Daten
Juliane Schwille-Kiuntke 
1   Department of Internal Medicine VI: Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany
2   Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, Tübingen, Germany
,
Till Ittermann
3   Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
,
Carsten Oliver Schmidt
3   Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
,
Hans Jörgen Grabe
4   Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany
,
Markus M. Lerch
5   Department of Medicine A, University Medicine Greifswald, Greifswald, Germany
,
Henry Völzke
3   Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
,
Monika A. Rieger 
2   Institute of Occupational and Social Medicine and Health Services Research, University Hospital Tübingen, Tübingen, Germany
,
Paul Enck 
1   Department of Internal Medicine VI: Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany
,
Birgit Schauer
3   Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
› Author AffiliationsSupported by: Federal Ministry of Education and Research 01ZZ9603, 01ZZ0103, 01ZZ0403
Supported by: Social Ministry of the Federal State of Mecklenburg-West Pomerania
Supported by: Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania
Supported by: The present analyses and the preparation of the manuscript were financed by own funds of the participating institutions. The work of the Institute of Occupational and Social Medicine and Health Services Research Tübingen is supported by an unrestricted grant of the employers´ association of the metal and electric industry Baden-Württemberg (Südwestmetall)
Supported by: JSK received a grant from the Faculty of Medicine, Tuebingen, Germany TÜFF no. 2399-0-0; 2016-2019
Supported by: JSK received a travel grant (German Society for Neurogastroenterology and Motility).
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background A proportion of irritable bowel syndrome (IBS) affected patients does not fulfil Rome criteria despite considerable impairment similarly to that in patients with organic gastrointestinal diseases.
This investigation aims to examine differences regarding Mental (MQoL), Physical Quality of Life (PQoL), and sleep between IBS according to Rome III (IBS Rome), clinically defined IBS, inflammatory bowel diseases (IBD), and non-IBS/non-IBD individuals.

Methods Data from SHIP-Trend (Study of Health in Pomerania, 2008–2012), a population-based cohort study in Germany, were used.

Results Response was 50.1% (N = 4420). Prevalence was 3.5% for IBS Rome (95% confidence interval (CI): 3.0 – 4.1%, n = 148), 0.6% for clinically defined IBS (CI: 0.4 – 0.9%, n = 27), and 0.8% for IBD (CI: 0.6 – 1.1%, n = 34). Individuals with IBS Rome (4.54 (CI: –5.92; –3.17)) and clinically defined IBS (4.69 (CI: –7.82; –1.56)) had lower scores for MQoL compared to the non-IBS/non-IBD group. PQoL scores were lowered in IBS Rome (6.39 (CI: –7.89; –4.88)) and IBD (5.37 (CI: –8.51; –2.22)), but not in clinically defined IBS compared to the non-IBS/non-IBD group. IBS Rome was the only gastroenterological condition with higher odds of sleeping problems (odds ratio (OR) “falling asleep”: 1.74; CI: 1.29; 2.36; OR “remaining asleep”: 1.73; CI: 1.26; 2.38).

Conclusions IBS Rome is associated with reduced MQoL, PQoL, and sleep problems. Clinically defined IBS is associated only with reduced MQoL. Heterogeneity within IBS affected patients should be considered in clinical routine and screening for daily life impairment should be performed.

Zusammenfassung

Hintergrund Eine Subgruppe von Personen mit Reizdarmsyndrom (RDS) erfüllt trotz Einschränkungen, die denen von somatisch gastroenterologisch Erkrankten ähneln, nicht die Rom III-Kriterien.

In dieser Studie werden die mentale (MQoL) und körperliche (PQoL) Lebensqualität sowie das Schlafverhalten bei Personen verglichen, die ein RDS nach Rom III, ein klinisch definiertes RDS (ohne Erfüllung der Rom III-Kriterien), eine chronisch-entzündliche Darmerkrankung (CED) oder nichts dergleichen haben.

Methoden Es wurden Daten der SHIP-Studie (Study of Health in Pomerania, 2008–2012), einer populationsbasierten Kohortenstudie in Deutschland, ausgewertet.

Ergebnisse Die Response war 50,1% (N = 4420). Die Prävalenz betrug 3,5% für ein RDS gemäß Rom III (95% Konfidenzintervall [KI]: 3,0 – 4,1%, n = 148), 0,6% für ein klinisch definiertes RDS (KI: 0,4 – 0,9%, n = 27), und 0,8% für eine CED (KI: 0,6 – 1,1%, n = 34). Personen mit RDS gemäß Rom III (4,54 [KI: –5,92; –3,17]) und klinisch definiertem RDS (4,69 [KI: –7,82; –1,56]) hatten eine geringere MQoL als Personen aus der Subgruppe der nicht Erkrankten. Die PQoL war reduziert bei Personen mit RDS nach Rom III (6,39 [KI: –7,89; –4,88]) und CED (5,37 [KI: –8,51; –2,22]), aber nicht bei klinisch definiertem RDS im Vergleich zur Subgruppe ohne diese Erkrankungen. RDS nach Rom III war die einzige gastroenterologische Erkrankung mit einem erhöhten Odds für Schlafprobleme (odds ratio [OR] „Einschlafprobleme“: 1,74; KI: 1,29; 2,36; OR „Durchschlafprobleme“: 1,73; KI: 1,26; 2,38).

Schlussfolgerungen Ein RDS nach Rom III geht mit reduzierter MQoL, PQoL und Schlafproblemen einher. Klinisch definiertes RDS ist nur mit einer reduzierten MQoL vergesellschaftet. Im klinischen Alltag sollten die Heterogenität dieses Patientenkollektivs Beachtung finden und Beeinträchtigungen des alltäglichen Lebens erhoben werden.

Schlüsselwörter

Lebensqualität - Schlaf - Reizdarmsyndrom - Epidemiologie

Keywords

Quality of life - Sleep - Irritable bowel syndrome - Epidemiology

Supporting information



Publication History

Received: 07 April 2021

Accepted after revision: 23 November 2021

Article published online:
09 March 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Enck P, Aziz Q, Barbara G. et al. Irritable bowel syndrome. Nat Rev Dis Primers 2016; 2: 16014
    CrossrefPubMedSearch in Google Scholar
  • 2 Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721
    CrossrefPubMedSearch in Google Scholar
  • 3 Schwille-Kiuntke J, Frick J-S, Zanger P. et al. Post-infectious irritable bowel syndrome--a review of the literature. Z Gastroenterol 2011; 49: 997-1003
    Thieme ConnectPubMedSearch in Google Scholar
  • 4 Sperber AD, Shvartzman P, Friger M. et al. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?. Eur J Gastroenterol Hepatol 2007; 19: 441-447
    CrossrefPubMedSearch in Google Scholar
  • 5 Manning AP, Thompson WG, Heaton KW. et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-654
    CrossrefPubMedSearch in Google Scholar
  • 6 Lacy BE, Mearin F, Chang L. et al. Bowel Disorders. Gastroenterology 2016; 150: 1393-1407
    CrossrefPubMedSearch in Google Scholar
  • 7 Camilleri M. Irritable Bowel Syndrome: Straightening the road from the Rome criteria. Neurogastroenterol Motil 2020; 32: e13957
    CrossrefPubMedSearch in Google Scholar
  • 8 Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology 2016; 150: 1262-1279
    CrossrefPubMedSearch in Google Scholar
  • 9 Black CJ, Yiannakou Y, Guthrie EA. et al. A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles. Am J Gastroenterol 2021; 116: 372-381
    CrossrefPubMedSearch in Google Scholar
  • 10 International Classification of Diseases Version 10 (ICD-10-GM Version 2021). www.dimdi.de, last access: 08th February 2021.
    PubMed
  • 11 Schwille-Kiuntke J, Rüdlin SL, Junne F. et al. Illness perception and health care use in individuals with irritable bowel syndrome: results from an online survey. BMC Fam Prac 2021; 22: 154
    CrossrefPubMedSearch in Google Scholar
  • 12 Layer P, Andresen V, Pehl C. et al. [Irritable Bowel Syndrome: German Consensus Guidelines on Definition, Pathophysiology and Management. German Society of Digestive and Metabolic Diseases (DGVS) and German Society of Neurogastroenterology and Motility (DGNM)]. Z Gastroenterol 2011; 49: 237–293 Updated version (June 2021). Available: https://www.awmf.org/uploads/tx_szleitlinien/021-016l_S3_Definition-Pathophysiologie-Diagnostik-Therapie-Reizdarmsyndroms_2021-07.pdf, last access: 12th December 2021..
    Thieme ConnectPubMed
  • 13 Mujagic Z, Jonkers D, Hungin APS. et al. Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries. Eur J Gastroenterol Hepatol 2017; 29: 651-656
    CrossrefPubMedSearch in Google Scholar
  • 14 Spiegel BMR, Farid M, Esrailian E. et al. Is irritable bowel syndrome a diagnosis of exclusion?: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 2010; 105: 848-858
    CrossrefPubMedSearch in Google Scholar
  • 15 Schauer B, Grabe HJ, Ittermann T. et al. Irritable bowel syndrome, mental health, and quality of life: Data from a population-based survey in Germany (SHIP-Trend-0). Neurogastroenterol Motil 2019; 31: e13511
    CrossrefPubMedSearch in Google Scholar
  • 16 Völzke H, Alte D, Schmidt CO. et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 2011; 40: 294-307
    CrossrefPubMedSearch in Google Scholar
  • 17 Ware JJ, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical care 1996; 34: 220-233
    CrossrefPubMedSearch in Google Scholar
  • 18 Stubbe B, Penzel T, Fietze I. et al. Polysomnography in a Large Population Based Study-the Study of Health in Pomerania Protocol. J Sleep Disord Manag 2016; 2: 1-5
    CrossrefPubMedSearch in Google Scholar
  • 19 Longstreth GF, Thompson WG, Chey WD. et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491
    CrossrefPubMedSearch in Google Scholar
  • 20 Han KT, Park EC, Kim JH. et al. Is marital status associated with quality of life?. Health Qual Life Outcomes 2014; 12: 109
    CrossrefPubMedSearch in Google Scholar
  • 21 Ross CE, Van Willigen M. Education and the subjective quality of life. J Health Soc Behav 1997; 38: 275-297
    CrossrefPubMedSearch in Google Scholar
  • 22 Norström F, Waenerlund A-K, Lindholm L. et al. Does unemployment contribute to poorer health-related quality of life among Swedish adults?. BMC public health 2019; 19: 457
    CrossrefPubMedSearch in Google Scholar
  • 23 Walker EA, Gelfand A, Katon WJ. et al. Adult health status of women with histories of childhood abuse and neglect. Am J Med 1999; 107: 332-339
    CrossrefPubMedSearch in Google Scholar
  • 24 Emamvirdi R, Hosseinzadeh Asl N, Colakoglu FF. Health-Related Quality of Life With Regard to Smoking, Consumption of Alcohol, and Sports Participation. Iran Red Crescent Med J 2016; 18: e27919
    CrossrefPubMedSearch in Google Scholar
  • 25 Addante R, Naliboff B, Shih W. et al. Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals. J Clin Gastroenterol 2019; 53: e142-e149
    CrossrefPubMedSearch in Google Scholar
  • 26 Cassar GE, Youssef GJ, Knowles S. et al. Health-Related Quality of Life in Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. Gastroenterol Nurses 2020; 43: E102-E122
    CrossrefPubMedSearch in Google Scholar
  • 27 Buono JL, Carson RT, Flores NM. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes 2017; 15: 35
    CrossrefPubMedSearch in Google Scholar
  • 28 Weerts ZRM, Vork L, Mujagic Z. et al. Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome. Neurogastroenterol Motil 2019; 31: e13629
    CrossrefPubMedSearch in Google Scholar
  • 29 Basnayake C, Kamm MA, Stanley A. et al. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial. Lancet Gastroenterol Hepatol 2020; 5: 890-899
    CrossrefPubMedSearch in Google Scholar
  • 30 Paré P, Gray J, Lam S. et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther 2006; 28: 1726-1735
    CrossrefPubMedSearch in Google Scholar
  • 31 Groll D, Vanner SJ, Depew WT. et al. The IBS-36: a new quality of life measure for irritable bowel syndrome. Am J Gastroenterol 2002; 97: 962-971
    CrossrefPubMedSearch in Google Scholar
  • 32 Gralnek IM, Hays RD, Kilbourne A. et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000; 119: 654-660
    CrossrefPubMedSearch in Google Scholar
  • 33 Enck P, Leinert J, Smid M. et al. Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO Study. Gastroenterol Res Pract 2016; 2016: 3186016
    CrossrefPubMedSearch in Google Scholar
  • 34 Michalsen VL, Per Olav Vandvik PO, Farup PG. Predictors of health-related quality of life in patients with irritable bowel syndrome. A cross-sectional study in Norway. Health Qual Life Outcomes 2015; 13: 113
    CrossrefPubMedSearch in Google Scholar
  • 35 Polster A, Van Oudenhove L, Jones M. et al. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms. Aliment Pharmacol Ther 2017; 46: 529-539
    CrossrefPubMedSearch in Google Scholar
  • 36 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. Arlington: American Psychiatric Association; 2013
    CrossrefSearch in Google Scholar
  • 37 Wallander MA, Johansson S, Ruigómez A. et al. Morbidity associated with sleep disorders in primary care: a longitudinal cohort study. Prim Care Companion J Clin Psychiatry 2007; 9: 338-345
    CrossrefPubMedSearch in Google Scholar
  • 38 Tu Q, Heitkemper MM, Jarrett ME. et al. Sleep disturbances in irritable bowel syndrome: a systematic review. Neurogastroenterol Motil 2017; 29 (03)
    CrossrefPubMedSearch in Google Scholar
  • 39 Fass R, Fullerton S, Tung S. et al. Sleep disturbances in clinic patients with functional bowel disorders. Am J Gastroenterol 2000; 95: 1195-2000
    CrossrefPubMedSearch in Google Scholar
  • 40 Kim SY, Choung RS, Lee SK. et al. Self-reported Sleep Impairment in Functional Dyspepsia and Irritable Bowel Syndrome. J Neurogastroenterol Motil 2018; 24: 280-288
    CrossrefPubMedSearch in Google Scholar
  • 41 Tkalcić M, Hauser G, Stimac D. Differences in the health-related quality of life, affective status, and personality between irritable bowel syndrome and inflammatory bowel disease patients. Eur J Gastroenterol Hepatol 2010; 22: 862-867
    CrossrefPubMedSearch in Google Scholar
  • 42 Mikocka-Walus A, Knowles SR, Keefer L. et al. Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases. Inflamm Bowel Dis 2016; 22: 752-762
    CrossrefPubMedSearch in Google Scholar
  • 43 Ansari R, Attari F, Razjouyan H. et al. Ulcerative colitis and irritable bowel syndrome: relationships with quality of life. Eur J Gastroenterol Hepatol 2008; 20: 46-50
    CrossrefPubMedSearch in Google Scholar
  • 44 Zargar A, Gooraji SA, Keshavarzi B. et al. Effect of Irritable Bowel Syndrome on Sleep Quality and Quality of Life of Inflammatory Bowel Disease in Clinical Remission. Int J Prev Med 2019; 10: 10
    CrossrefPubMedSearch in Google Scholar
  • 45 Ruffle JK, Tinkler L, Emmett C. et al. Constipation Predominant Irritable Bowel Syndrome and Functional Constipation Are Not Discrete Disorders: A Machine Learning Approach. Am J Gastroenterol 2021; 116: 142-151
    CrossrefPubMedSearch in Google Scholar
  • 46 Frieling T, Schemann M, Pehl C. Irritable bowel syndrom--a misnomer?. Z Gastroenterol 2011; 49: 577-578
    Thieme ConnectPubMedSearch in Google Scholar
  • 47 Enck P, Frieling T, Schemann M. Irritable bowel syndrome – disection of a disease. A 13-steps polemic. Z Gastroenterol 2017; 55: e1
    Thieme ConnectPubMedSearch in Google Scholar
  • 48 Polster AV, Palsson OS, Törnblom H. et al. Subgroups of IBS patients are characterized by specific, reproducible profiles of GI and non-GI symptoms and report differences in healthcare utilization: A population-based study. Neurogastroenterol Motil 2019; 31: e13483
    CrossrefPubMedSearch in Google Scholar
  • 49 Van den Houte K, Carbone F, Pannemans J. et al. Prevalence and impact of self-reported irritable bowel symptoms in the general population. United European Gastroenterol J 2019; 7: 307-315
    CrossrefPubMedSearch in Google Scholar
  • 50 Buysse DJ, Reynolds CFr, Monk TH. et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213
    CrossrefPubMedSearch in Google Scholar